Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Meitav BioTechnology Fund

+ Add to Watchlist

METBITE:IT

339.26 ILs 0.74 0.22%

As of 00:59:30 ET on 03/25/2015.

Snapshot for Meitav BioTechnology Fund (METBITE)

Year To Date: +10.88% 3-Month: +10.91% 3-Year: +31.37% 52-Week Range: 227.27 - 358.05
1-Month: +0.68% 1-Year: +42.34% 5-Year: +18.69% Beta vs TA-100: 0.72

Mutual Fund Chart for METBITE

No chart data available.
  • METBITE:IT 339.26
  • 1M
  • 1Y
Interactive METBITE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for METBITE

Meitav BioTechnology Fund is an open-end fund incorporated in Israel. The Fund invests at least 50% of it's assets in shares of Corporations from the BioTechnology industry across the globe.

Inception Date: 03-28-2000 Telephone: 972-3-777-8000
Managers: ZVI STEPAK
Web Site: www.meitavgroup.com/

Fundamentals for METBITE

NAV -
Assets (M) (on 2015-02-27) 57.70
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for METBITE

No dividends reported

Fees & Expenses for METBITE

Front Load 0.00
Back Load -
Current Mgmt Fee 3.20
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for METBITE

Filing Date: 11/30/2014
Name Position Value % of Total
iShares Nasdaq Biotechnology E 2,900 3,411,214 9.034%
Amgen Inc 5,000 3,188,156 8.443%
First Trust NYSE Arca Biotechn 8,000 3,155,639 8.357%
Gilead Sciences Inc 8,000 3,106,091 8.226%
SPDR S&P Biotech ETF 4,400 3,074,519 8.142%
Celgene Corp 6,500 2,833,437 7.504%
Novartis AG 7,000 2,589,389 6.858%
Biogen Inc 1,400 1,652,484 4.376%
Actavis plc 1,500 1,570,484 4.159%
CVS Health Corp 3,500 1,231,423 3.261%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil